https://genvivoinc.com/ 2025-11-05T21:40:12+00:00 daily 1.0 https://genvivoinc.com/about/ 2026-06-16T18:19:53+00:00 daily 0.8 https://genvivoinc.com/platform/ 2025-11-14T18:20:05+00:00 daily 0.8 https://genvivoinc.com/pipeline/ 2025-10-27T17:41:01+00:00 daily 0.8 https://genvivoinc.com/pressreleases/ 2025-05-04T20:43:06+00:00 daily 0.8 https://genvivoinc.com/contact/ 2026-06-16T18:46:46+00:00 daily 0.8 https://genvivoinc.com/our-organization/ 2025-11-12T00:25:55+00:00 daily 0.8 https://genvivoinc.com/leadership/ 2026-06-16T18:25:02+00:00 daily 0.8 https://genvivoinc.com/team/alan-ashworth-phd-frs/ 2025-11-20T23:52:36+00:00 daily 0.8 https://genvivoinc.com/publications/ 2025-11-07T18:56:03+00:00 daily 0.8 https://genvivoinc.com/2023/05/19/genvivo-to-present-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/ 2024-08-30T23:24:47+00:00 daily 0.8 https://genvivoinc.com/2023/11/04/genvivo-to-present-at-the-2023-society-for-immunotherapy-of-cancer-sitc-annual-meeting/ 2024-07-26T18:02:02+00:00 daily 0.8 https://genvivoinc.com/2024/03/12/genvivo-to-present-at-the-2024-bioprocess-international-bpi-us-west-annual-meeting/ 2024-07-26T18:01:49+00:00 daily 0.8 https://genvivoinc.com/2024/04/10/genvivo-to-present-at-the-2024-american-association-for-cancer-research-aacr-annual-meeting/ 2024-07-26T18:01:38+00:00 daily 0.8 https://genvivoinc.com/2024/05/08/genvivo-to-present-pipeline-programs-at-the-2024-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/ 2024-07-26T18:00:45+00:00 daily 0.8 https://genvivoinc.com/news/ 2025-08-26T16:49:05+00:00 daily 0.8 https://genvivoinc.com/2024/06/27/genvivo-announces-initiation-of-patient-dosing-in-a-us-phase-i-ib-clinical-trial-evaluating-gen2-a-personalizing-gene-vector-immunotherapy-in-patients-with-advanced-solid-tumors/ 2024-08-30T23:13:40+00:00 daily 0.8 https://genvivoinc.com/2024/11/08/genvivo-to-present-phase-1-trial-results-for-gen2-a-personalizing-gene-vector-therapy-at-the-2024-society-for-immunotherapy-of-cancer-sitc-annual-meeting/ 2024-11-09T01:40:35+00:00 daily 0.8 https://genvivoinc.com/2025/04/25/genvivo-highlights-gen-1013-a-novel-delivery-of-an-il-12-immunotherapy-at-the-2025-american-association-for-cancer-research-aacr-annual-meeting/ 2025-08-26T02:46:46+00:00 daily 0.8 https://genvivoinc.com/2025/05/21/genvivo-highlights-non-integrating-retroviral-vector-technology-with-persistent-payload-expression-at-the-2025-retroviruses-meeting/ 2025-08-26T02:45:11+00:00 daily 0.8 https://genvivoinc.com/2025/05/14/genvivo-highlights-gen2-phase-1-data-and-gen-1013-preclinical-data-at-the-2025-american-society-of-gene-cell-therapy-asgct-annual-meeting/ 2025-08-26T02:46:17+00:00 daily 0.8 https://genvivoinc.com/genvivo-highlights-gen-1013-a-novel-delivery-of-an-il-12-immunotherapy-at-the-2025-american-association-for-cancer-research-aacr-annual-meeting-2/ 2025-09-12T16:55:12+00:00 daily 0.8 https://genvivoinc.com/culture/ 2025-10-23T22:34:34+00:00 daily 0.8 https://genvivoinc.com/2025/09/11/genvivo-strengthens-oncology-leadership-with-appointment-of-noriyuki-kasahara-m-d-ph-d-as-chief-scientific-officer/ 2025-09-12T15:38:49+00:00 daily 0.8 https://genvivoinc.com/manufacturing/ 2025-11-05T18:47:27+00:00 daily 0.8 https://genvivoinc.com/in-vivo-car-t/ 2025-10-24T19:32:34+00:00 daily 0.8 https://genvivoinc.com/advantages-of-in-vivo-car-t-therapy/ 2025-10-24T19:23:06+00:00 daily 0.8 https://genvivoinc.com/g-volve-vectors-provide-an-efficacy-advantage/ 2025-10-24T19:24:17+00:00 daily 0.8 https://genvivoinc.com/g-volve-platform-car-product-development/ 2025-10-24T19:25:49+00:00 daily 0.8 https://genvivoinc.com/g-volve-vectors-incorporate-both-transcriptional-and-translational-regulatory-sequences/ 2025-10-24T19:26:58+00:00 daily 0.8 https://genvivoinc.com/team/malcolm-k-brenner-m-d-ph-d/ 2025-10-09T20:49:46+00:00 daily 0.8 https://genvivoinc.com/team/2722-2/ 2025-10-09T20:53:47+00:00 daily 0.8 https://genvivoinc.com/team/steve-gruber-md-phd-mph/ 2024-12-09T17:00:55+00:00 daily 0.8 https://genvivoinc.com/team/carl-june-m-d/ 2025-10-09T21:11:51+00:00 daily 0.8 https://genvivoinc.com/team/richard-koya-m-d-ph-d/ 2025-10-09T20:40:43+00:00 daily 0.8 https://genvivoinc.com/team/parvis-shamlou-phd/ 2025-11-14T18:21:25+00:00 daily 0.8 https://genvivoinc.com/team/pin-wang-phd/ 2024-07-11T15:31:21+00:00 daily 0.8 https://genvivoinc.com/team/2058-2/ 2025-11-20T23:55:18+00:00 daily 0.8 https://genvivoinc.com/team/2061-2/ 2024-07-22T20:53:32+00:00 daily 0.8 https://genvivoinc.com/team/nori-kasahara-md-phd-2/ 2025-08-26T23:19:27+00:00 daily 0.8 https://genvivoinc.com/team/alison-l-hannah-m-d/ 2025-10-31T22:08:55+00:00 daily 0.8 https://genvivoinc.com/team/carol-stuckley/ 2025-09-12T16:28:29+00:00 daily 0.8 https://genvivoinc.com/team/victor-constantinescu/ 2024-07-11T15:35:13+00:00 daily 0.8 https://genvivoinc.com/team/lynn-svay/ 2025-08-08T23:01:52+00:00 daily 0.8 https://genvivoinc.com/team/joseph-mcnulty-ph-d/ 2025-07-08T16:19:30+00:00 daily 0.8 https://genvivoinc.com/team/matthew-romeo/ 2024-07-11T15:34:07+00:00 daily 0.8 https://genvivoinc.com/team/geraldine-albino/ 2024-07-11T15:34:57+00:00 daily 0.8 https://genvivoinc.com/team/li-liu/ 2024-07-11T15:34:29+00:00 daily 0.8 https://genvivoinc.com/team/sarah-collins/ 2024-05-30T22:34:48+00:00 daily 0.8